Vaxfab Enterp.

Why is Vaxfab Enterprises Ltd falling/rising?

As of 01-Sep, Vaxfab Enterprises Ltd's stock price is falling, with a decline of 2.73% and underperformance against its sector. Despite a significant increase over the past year, recent trends indicate negative market sentiment and consecutive price drops.

As of 01-Sep, Vaxfab Enterprises Ltd's stock price is currently falling, as indicated by a change of -1.85, which represents a decline of 2.73%. The stock has been underperforming in the market, having lost 6.32% over the last two days. Additionally, today's performance shows that it has underperformed its sector by 1.91%. <BR><BR>The stock has also touched an intraday low of Rs 66, which reflects the downward trend. Although the stock has shown strong performance over longer periods, such as a 178.48% increase over the past year and a 75.39% increase year-to-date, the recent short-term performance indicates a decline. <BR><BR>Despite the falling price, there has been a rise in investor participation, with delivery volume increasing by 21.09% against the 5-day average. However, this increase in trading volume has not translated into a price increase, suggesting that the current market sentiment is negative. Overall, the combination of recent price declines, underperformance against the sector, and the stock's consecutive falls contribute to the current downward movement in Vaxfab Enterprises Ltd's stock price.

Who are in the management team of Vaxfab Enterp.?

The management team of Vaxfab Enterprises includes Komal Jain (Company Secretary), Devi Singh (Managing Director), Premaram Patel (Independent Director), Kailash Gupta (Non-Executive Director), and Chinu Kalal (Independent Director).

The management team of Vaxfab Enterprises includes the following individuals:<BR><BR>- **Komal Jain** - Company Secretary<BR>- **Devi Singh** - Managing Director<BR>- **Premaram Patel** - Independent Director<BR>- **Kailash Gupta** - Non-Executive Director<BR>- **Chinu Kalal** - Independent Director<BR><BR>If you need more information about their roles or the company, feel free to ask!

What does Vaxfab Enterp. do?

Vaxfab Enterprises Ltd, a Micro Cap company incorporated in 1983, trades in fabrics and garments. As of June 2026, it reported net sales of 0 Cr and a net profit of -3 Cr, with a market cap of INR 183 Cr.

Overview: <BR>Vaxfab Enterprises Ltd is engaged in the trading of fabrics and garments within the Trading & Distributors industry and is classified as a Micro Cap company.<BR><BR>History: <BR>Vaxfab Enterprises Ltd was incorporated on 9th February 1983 in West Bengal. The company was formerly known as Ellora Trading Limited and changed its name on July 16, 2022. The latest quarterly results reported net sales and profit for the period ending June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: -3 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 183 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 21 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.95 <BR>Return on Equity: -10.60% <BR>Price to Book: 4.17 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the Vaxfab Enterp.?

Vaxfab Enterp.'s peers include Northern Spirits, Signet Industrie, Maximus Interna., Rama Vision, Parshva Enterpr., Metroglobal, Dhoot Indl.Fin, Amrapali Inds., and Stratmont Indus. Vaxfab Enterp. has below-average management risk and growth, with a 1-year return of 204.12%, while Rama Vision leads with a 110.03% return.

Peers: The peers of Vaxfab Enterp. are Northern Spirits, Signet Industrie, Maximus Interna., Rama Vision, Parshva Enterpr., Metroglobal, Dhoot Indl.Fin, Amrapali Inds., Stratmont Indus.<BR><BR>Quality Snapshot: Excellent management risk is observed at Rama Vision, Dhoot Indl.Fin, and Stratmont Indus, while Average management risk is found at Northern Spirits, Signet Industrie, Maximus Interna., and the rest. Below Average management risk is noted for Vaxfab Enterp., Parshva Enterpr., Amrapali Inds., and East India Drums. Growth is Excellent for Rama Vision, Dhoot Indl.Fin, Amrapali Inds., and the rest, while Average growth is seen at Maximus Interna. and the rest, and Below Average growth is present at Signet Industrie, Parshva Enterpr., Vaxfab Enterp., and Metroglobal. Capital Structure ratings show Excellent at Metroglobal, Good at Parshva Enterpr. and Dhoot Indl.Fin, while Below Average is noted for Vaxfab Enterp., Northern Spirits, Signet Industrie, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Rama Vision at 110.03%, while the lowest is Northern Spirits at -30.97%. Vaxfab Enterp. has a significantly higher 1-year return of 204.12%. Additionally, the peers with negative six-month returns include Stratmont Indus and East India Drums.

How big is Vaxfab Enterp.?

As of 31st August, Vaxfab Enterprises Ltd has a market capitalization of 183.00 Cr, with net sales of 86.76 Cr and a net loss of 11.80 Cr over the latest four quarters. As of March 2023, shareholder's funds were 16.47 Cr and total assets were 26.58 Cr.

As of 31st August, Vaxfab Enterprises Ltd has a market capitalization of 183.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Vaxfab Enterprises Ltd reported Net Sales of 86.76 Cr. However, the company experienced a loss of 11.80 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2023, where Shareholder's Funds amounted to 16.47 Cr and Total Assets were reported at 26.58 Cr.

Which are the latest news on Vaxfab Enterp.?

Should I buy, sell or hold Vaxfab Enterprises Ltd?

When is the next results date for Vaxfab Enterprises Ltd?

The next results date for Vaxfab Enterprises Ltd is 14 August 2026.

The next results date for Vaxfab Enterprises Ltd is scheduled for 14 August 2026.

Are Vaxfab Enterprises Ltd latest results good or bad?

Vaxfab Enterprises Ltd's latest Q3 FY26 results are concerning, showing a net loss of ₹3.24 crores compared to a profit of ₹6.41 crores last year, alongside a 71.55% revenue decline. The company's financial performance indicates significant challenges and volatility, warranting caution from investors.

Vaxfab Enterprises Ltd's latest results for Q3 FY26 are concerning. The company reported a net loss of ₹3.24 crores, a significant decline compared to a net profit of ₹6.41 crores in the same quarter last year. This marks a dramatic reversal in performance, reflecting operational challenges and a sharp decline in revenue, which fell by 71.55% quarter-on-quarter to ₹15.66 crores.<BR><BR>The operating margin also collapsed to just 2.04%, down from 13.92% a year ago, indicating severe margin compression. Additionally, the company faced an extraordinary negative other income charge of ₹3.37 crores, which has raised questions about the sustainability of its business model.<BR><BR>While Vaxfab's return on equity (ROE) remains strong at 55.06%, the overall financial performance shows significant volatility and deterioration. The company's Mojo Score of 54/100 and a HOLD rating suggest that investors should exercise caution. Given these results, the outlook appears challenging, and the company faces substantial headwinds moving forward.

Is Vaxfab Enterp. overvalued or undervalued?

As of November 17, 2025, Vaxfab Enterprises is considered undervalued with a PE ratio of 4.69, an EV to EBIT of 3.44, a ROCE of 61.79%, and a PEG ratio of 0.02, significantly outperforming peers and the Sensex, with a year-to-date return of 247.66%.

As of 17 November 2025, Vaxfab Enterprises has moved from a fair to a very attractive valuation grade. The company is currently considered undervalued, supported by a PE ratio of 4.69, an EV to EBIT of 3.44, and a remarkable ROCE of 61.79%. In comparison to peers, Vaxfab's valuation metrics stand out significantly; for instance, Elitecon International has a PE ratio of 294.38, while PTC India, another attractive peer, has a PE ratio of 7.56.<BR><BR>The company's strong performance is further underscored by its PEG ratio of 0.02, indicating substantial growth potential relative to its price. Despite a recent dip in stock price, Vaxfab has demonstrated impressive returns year-to-date at 247.66%, significantly outperforming the Sensex's 8.72% during the same period. Overall, the compelling valuation ratios and robust performance metrics suggest that Vaxfab Enterprises is indeed undervalued in the current market.

How has been the historical performance of Vaxfab Enterp.?

Vaxfab Enterp. experienced significant growth from March 2022 to March 2023, with net sales rising to 16.75 Cr from 0.27 Cr, and a profit after tax of 0.33 Cr compared to 0.00 Cr the previous year. Total assets increased to 26.58 Cr from 3.15 Cr, indicating a strong financial improvement.

Answer:<BR>The historical performance of Vaxfab Enterp. shows significant growth from March 2022 to March 2023.<BR><BR>Breakdown:<BR>In March 2023, Vaxfab Enterp. reported net sales of 16.75 Cr, a substantial increase from 0.27 Cr in March 2022. Total operating income also rose to 16.75 Cr from 0.27 Cr, while total expenditure increased to 16.29 Cr from 0.36 Cr. The operating profit (PBDIT) improved to 0.46 Cr from a loss of 0.09 Cr, resulting in a profit before tax of 0.45 Cr compared to no profit in the previous year. Consequently, the profit after tax reached 0.33 Cr, up from 0.00 Cr. The consolidated net profit for March 2023 was 0.39 Cr, reflecting a notable improvement from the previous year's figure of 0.00 Cr. The company's equity capital increased to 8.40 Cr from 1.20 Cr, and total assets grew to 26.58 Cr from 3.15 Cr. Additionally, cash flow from operating activities was 1.00 Cr, with a net cash inflow of 4.00 Cr, indicating a positive cash position compared to the previous year.

Who are the top shareholders of the Vaxfab Enterp.?

The top shareholders of Vaxfab Enterprises are primarily individual investors, holding 81.84% of the shares, with Varsha Vaibhav Patil as the largest public shareholder at 8.45%. There are no institutional investors or pledged promoter holdings.

The top shareholders of Vaxfab Enterprises include individual investors, who hold a significant 81.84% of the company's shares. Among public shareholders, Varsha Vaibhav Patil stands out with a holding of 8.45%. There are no institutional investors or mutual funds currently holding shares in the company, and there are no pledged promoter holdings.

What is the technical trend for Vaxfab Enterp.?

As of May 16, 2025, Vaxfab Enterprises shows a strong bullish trend supported by positive MACD, Bollinger Bands, and moving averages across weekly and monthly time frames.

As of 16 May 2025, the technical trend for Vaxfab Enterp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting a strong upward momentum. Bollinger Bands also indicate a bullish stance on both time frames. The daily moving averages confirm a bullish trend as well. The KST is bullish on the weekly and mildly bullish on the monthly, while Dow Theory shows a mildly bullish outlook in both time frames. Overall, the current technical stance is bullish with strong indicators supporting this trend.

Has Vaxfab Enterp. declared dividend?

No Dividend History Available